To determine the frequency of Group B Streptococcal colonization of vagina in women at 35-37 week pregnancy
Introduction: Group B streptococci (GBS) is usually present in a vaginal canal in micro-flora, which usually do not exhibit any symptoms. Instead, in pregnancy, there are certain situations in GBS colonization in the vagina, which may lead to several complications.
Objective: To determine the frequency of Group B Streptococcal colonization of the vagina in women at 35-37 weeks of pregnancy.
Study Design: Cross-sectional survey
Setting: Antenatal clinic, Shalamar Hospital Lahore
Study duration: 6 month i.e. From: 05-09-2014 to 06-03-2015
Materials and Methods: 350 Booked Patients attending antenatal clinic at Shalamar hospital at 35-37 weeks of pregnancy for routine antenatal checkups were included. Lower vaginal swabs were taken without speculum using sterilized disposable cotton swab and transported to Amies Agar jell and transported to microbiology lab within 24 hours. Laboratory report was collected and reviewed by researcher regarding positive or negative culture for GBS. Patients with positive GBS culture were given intrapartum antibiotics.
Results: In our study, out of 350 cases, with the mean age of 26.92+4.84 years. Frequency of GBS colonization of vagina in women at 35-37 week pregnancy was recorded in 12.29% while remaining 87.71% had no findings of the morbidity.
Conclusion: It was concluded that the frequency of GBS colonization of vagina in women at 35-37 week of pregnancy is not very higher.
2. Chaudhry BY, Akhtar N, Balouch AH. Vaginal carriage rate of group B Streptococcus in pregnant women and its transmission to neonates. Journal of Ayub Medical College Abbottabad 2010;22(4):167-70.
3. Van Dyke MK, Phares CR, Lynfield R, Thomas AR, Arnold KE, Craig AS, et al. Evaluation of universal antenatal screening for group B streptococcus. New England Journal of Medicine 2009;360(25):2626-36.
4. Apgar BS, Greenberg GM, Yen G. Prevention of group B streptococcal disease in the newborn. American Family Physician 2005;71(5):903-10.
5. Barcaite E, Bartusevicius A, Tameliene R, Kliucinskas M, Maleckiene L, Nadisauskiene R. Prevalence of maternal group B streptococcal colonisation in European countries. Acta obstetricia et gynecologica Scandinavica 2008;87(3):260-71.
6. Namavar JB, POURARIAN S, POURBARFEHEI S. The prevalence and adverse effects of group B streptococcal colonization during pregnancy. 2008.
7. Turrentine MA, Ramirez MM. Recurrence of group B streptococci colonization in subsequent pregnancy. Obstetrics & Gynecology 2008;112(2):259-64.
8. Lawrence RS, Durch JS, Stratton KR. Vaccines for the 21st century: a tool for decisionmaking: National Academies Press; 2001.
9. Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, et al. Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. New England Journal of Medicine 2002;347(4):240-7.
Copyright (c) 2022 Sadia Azmat, Faiza Iqbal, Shabnam Tahir, Mariam Khalid, Sadia Mustafa, Wajeeha Asghar Alvi
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
All research articles published in the Journal of Rawalpindi Medical College (JRMC) are fully open access: immediately freely available to read, download, and share. Copyrights of all articles published in JRMC are retained by the authors. First publication rights are granted to JRMC. The journal/publisher is not responsible for subsequent uses of the work.
All articles are published under the Creative Commons Attribution (CC BY-SA 4.0) license.